Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Therapy and Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Cancer Detection
1.2.3 Cancer Treatment
1.3 Market by Application
1.3.1 Global Cancer Therapy and Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Lung Cancer
1.3.3 Rectal Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapy and Testing Market Perspective (2018-2033)
2.2 Cancer Therapy and Testing Growth Trends by Region
2.2.1 Global Cancer Therapy and Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cancer Therapy and Testing Historic Market Size by Region (2018-2023)
2.2.3 Cancer Therapy and Testing Forecasted Market Size by Region (2024-2033)
2.3 Cancer Therapy and Testing Market Dynamics
2.3.1 Cancer Therapy and Testing Industry Trends
2.3.2 Cancer Therapy and Testing Market Drivers
2.3.3 Cancer Therapy and Testing Market Challenges
2.3.4 Cancer Therapy and Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapy and Testing Players by Revenue
3.1.1 Global Top Cancer Therapy and Testing Players by Revenue (2018-2023)
3.1.2 Global Cancer Therapy and Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Therapy and Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Therapy and Testing Revenue
3.4 Global Cancer Therapy and Testing Market Concentration Ratio
3.4.1 Global Cancer Therapy and Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Therapy and Testing Revenue in 2022
3.5 Cancer Therapy and Testing Key Players Head office and Area Served
3.6 Key Players Cancer Therapy and Testing Product Solution and Service
3.7 Date of Enter into Cancer Therapy and Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Therapy and Testing Breakdown Data by Type
4.1 Global Cancer Therapy and Testing Historic Market Size by Type (2018-2023)
4.2 Global Cancer Therapy and Testing Forecasted Market Size by Type (2024-2033)
5 Cancer Therapy and Testing Breakdown Data by Application
5.1 Global Cancer Therapy and Testing Historic Market Size by Application (2018-2023)
5.2 Global Cancer Therapy and Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cancer Therapy and Testing Market Size (2018-2033)
6.2 North America Cancer Therapy and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cancer Therapy and Testing Market Size by Country (2018-2023)
6.4 North America Cancer Therapy and Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Therapy and Testing Market Size (2018-2033)
7.2 Europe Cancer Therapy and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cancer Therapy and Testing Market Size by Country (2018-2023)
7.4 Europe Cancer Therapy and Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapy and Testing Market Size (2018-2033)
8.2 Asia-Pacific Cancer Therapy and Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cancer Therapy and Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Therapy and Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Therapy and Testing Market Size (2018-2033)
9.2 Latin America Cancer Therapy and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cancer Therapy and Testing Market Size by Country (2018-2023)
9.4 Latin America Cancer Therapy and Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapy and Testing Market Size (2018-2033)
10.2 Middle East & Africa Cancer Therapy and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cancer Therapy and Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Therapy and Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Invitae
11.1.1 Invitae Company Detail
11.1.2 Invitae Business Overview
11.1.3 Invitae Cancer Therapy and Testing Introduction
11.1.4 Invitae Revenue in Cancer Therapy and Testing Business (2018-2023)
11.1.5 Invitae Recent Development
11.2 Foundation Medicine
11.2.1 Foundation Medicine Company Detail
11.2.2 Foundation Medicine Business Overview
11.2.3 Foundation Medicine Cancer Therapy and Testing Introduction
11.2.4 Foundation Medicine Revenue in Cancer Therapy and Testing Business (2018-2023)
11.2.5 Foundation Medicine Recent Development
11.3 Guardant Health
11.3.1 Guardant Health Company Detail
11.3.2 Guardant Health Business Overview
11.3.3 Guardant Health Cancer Therapy and Testing Introduction
11.3.4 Guardant Health Revenue in Cancer Therapy and Testing Business (2018-2023)
11.3.5 Guardant Health Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Cancer Therapy and Testing Introduction
11.4.4 Illumina Revenue in Cancer Therapy and Testing Business (2018-2023)
11.4.5 Illumina Recent Development
11.5 Sysmex
11.5.1 Sysmex Company Detail
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Cancer Therapy and Testing Introduction
11.5.4 Sysmex Revenue in Cancer Therapy and Testing Business (2018-2023)
11.5.5 Sysmex Recent Development
11.6 Abingdon Health
11.6.1 Abingdon Health Company Detail
11.6.2 Abingdon Health Business Overview
11.6.3 Abingdon Health Cancer Therapy and Testing Introduction
11.6.4 Abingdon Health Revenue in Cancer Therapy and Testing Business (2018-2023)
11.6.5 Abingdon Health Recent Development
11.7 Sophia
11.7.1 Sophia Company Detail
11.7.2 Sophia Business Overview
11.7.3 Sophia Cancer Therapy and Testing Introduction
11.7.4 Sophia Revenue in Cancer Therapy and Testing Business (2018-2023)
11.7.5 Sophia Recent Development
11.8 NanoEntek
11.8.1 NanoEntek Company Detail
11.8.2 NanoEntek Business Overview
11.8.3 NanoEntek Cancer Therapy and Testing Introduction
11.8.4 NanoEntek Revenue in Cancer Therapy and Testing Business (2018-2023)
11.8.5 NanoEntek Recent Development
11.9 BGI
11.9.1 BGI Company Detail
11.9.2 BGI Business Overview
11.9.3 BGI Cancer Therapy and Testing Introduction
11.9.4 BGI Revenue in Cancer Therapy and Testing Business (2018-2023)
11.9.5 BGI Recent Development
11.10 Diagnosis
11.10.1 Diagnosis Company Detail
11.10.2 Diagnosis Business Overview
11.10.3 Diagnosis Cancer Therapy and Testing Introduction
11.10.4 Diagnosis Revenue in Cancer Therapy and Testing Business (2018-2023)
11.10.5 Diagnosis Recent Development
11.11 Exact Sciences
11.11.1 Exact Sciences Company Detail
11.11.2 Exact Sciences Business Overview
11.11.3 Exact Sciences Cancer Therapy and Testing Introduction
11.11.4 Exact Sciences Revenue in Cancer Therapy and Testing Business (2018-2023)
11.11.5 Exact Sciences Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Detail
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Cancer Therapy and Testing Introduction
11.12.4 AstraZeneca Revenue in Cancer Therapy and Testing Business (2018-2023)
11.12.5 AstraZeneca Recent Development
11.13 Bayer AG
11.13.1 Bayer AG Company Detail
11.13.2 Bayer AG Business Overview
11.13.3 Bayer AG Cancer Therapy and Testing Introduction
11.13.4 Bayer AG Revenue in Cancer Therapy and Testing Business (2018-2023)
11.13.5 Bayer AG Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Detail
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Cancer Therapy and Testing Introduction
11.14.4 Johnson & Johnson Revenue in Cancer Therapy and Testing Business (2018-2023)
11.14.5 Johnson & Johnson Recent Development
11.15 Pfizer Inc.
11.15.1 Pfizer Inc. Company Detail
11.15.2 Pfizer Inc. Business Overview
11.15.3 Pfizer Inc. Cancer Therapy and Testing Introduction
11.15.4 Pfizer Inc. Revenue in Cancer Therapy and Testing Business (2018-2023)
11.15.5 Pfizer Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer Therapy and Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cancer Detection
Table 3. Key Players of Cancer Treatment
Table 4. Global Cancer Therapy and Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Cancer Therapy and Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cancer Therapy and Testing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cancer Therapy and Testing Market Share by Region (2018-2023)
Table 8. Global Cancer Therapy and Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Cancer Therapy and Testing Market Share by Region (2024-2033)
Table 10. Cancer Therapy and Testing Market Trends
Table 11. Cancer Therapy and Testing Market Drivers
Table 12. Cancer Therapy and Testing Market Challenges
Table 13. Cancer Therapy and Testing Market Restraints
Table 14. Global Cancer Therapy and Testing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cancer Therapy and Testing Market Share by Players (2018-2023)
Table 16. Global Top Cancer Therapy and Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Therapy and Testing as of 2022)
Table 17. Ranking of Global Top Cancer Therapy and Testing Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cancer Therapy and Testing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Therapy and Testing Product Solution and Service
Table 21. Date of Enter into Cancer Therapy and Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Therapy and Testing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cancer Therapy and Testing Revenue Market Share by Type (2018-2023)
Table 25. Global Cancer Therapy and Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Cancer Therapy and Testing Revenue Market Share by Type (2024-2033)
Table 27. Global Cancer Therapy and Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cancer Therapy and Testing Revenue Market Share by Application (2018-2023)
Table 29. Global Cancer Therapy and Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Cancer Therapy and Testing Revenue Market Share by Application (2024-2033)
Table 31. North America Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Cancer Therapy and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cancer Therapy and Testing Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Cancer Therapy and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cancer Therapy and Testing Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Cancer Therapy and Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Cancer Therapy and Testing Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cancer Therapy and Testing Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Cancer Therapy and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cancer Therapy and Testing Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Cancer Therapy and Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Cancer Therapy and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cancer Therapy and Testing Market Size by Country (2024-2033) & (US$ Million)
Table 46. Invitae Company Detail
Table 47. Invitae Business Overview
Table 48. Invitae Cancer Therapy and Testing Product
Table 49. Invitae Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 50. Invitae Recent Development
Table 51. Foundation Medicine Company Detail
Table 52. Foundation Medicine Business Overview
Table 53. Foundation Medicine Cancer Therapy and Testing Product
Table 54. Foundation Medicine Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 55. Foundation Medicine Recent Development
Table 56. Guardant Health Company Detail
Table 57. Guardant Health Business Overview
Table 58. Guardant Health Cancer Therapy and Testing Product
Table 59. Guardant Health Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 60. Guardant Health Recent Development
Table 61. Illumina Company Detail
Table 62. Illumina Business Overview
Table 63. Illumina Cancer Therapy and Testing Product
Table 64. Illumina Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 65. Illumina Recent Development
Table 66. Sysmex Company Detail
Table 67. Sysmex Business Overview
Table 68. Sysmex Cancer Therapy and Testing Product
Table 69. Sysmex Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 70. Sysmex Recent Development
Table 71. Abingdon Health Company Detail
Table 72. Abingdon Health Business Overview
Table 73. Abingdon Health Cancer Therapy and Testing Product
Table 74. Abingdon Health Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 75. Abingdon Health Recent Development
Table 76. Sophia Company Detail
Table 77. Sophia Business Overview
Table 78. Sophia Cancer Therapy and Testing Product
Table 79. Sophia Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 80. Sophia Recent Development
Table 81. NanoEntek Company Detail
Table 82. NanoEntek Business Overview
Table 83. NanoEntek Cancer Therapy and Testing Product
Table 84. NanoEntek Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 85. NanoEntek Recent Development
Table 86. BGI Company Detail
Table 87. BGI Business Overview
Table 88. BGI Cancer Therapy and Testing Product
Table 89. BGI Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 90. BGI Recent Development
Table 91. Diagnosis Company Detail
Table 92. Diagnosis Business Overview
Table 93. Diagnosis Cancer Therapy and Testing Product
Table 94. Diagnosis Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 95. Diagnosis Recent Development
Table 96. Exact Sciences Company Detail
Table 97. Exact Sciences Business Overview
Table 98. Exact Sciences Cancer Therapy and Testing Product
Table 99. Exact Sciences Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 100. Exact Sciences Recent Development
Table 101. AstraZeneca Company Detail
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Cancer Therapy and Testing Product
Table 104. AstraZeneca Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Bayer AG Company Detail
Table 107. Bayer AG Business Overview
Table 108. Bayer AG Cancer Therapy and Testing Product
Table 109. Bayer AG Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 110. Bayer AG Recent Development
Table 111. Johnson & Johnson Company Detail
Table 112. Johnson & Johnson Business Overview
Table 113. Johnson & Johnson Cancer Therapy and Testing Product
Table 114. Johnson & Johnson Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 115. Johnson & Johnson Recent Development
Table 116. Pfizer Inc. Company Detail
Table 117. Pfizer Inc. Business Overview
Table 118. Pfizer Inc. Cancer Therapy and Testing Product
Table 119. Pfizer Inc. Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 120. Pfizer Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Therapy and Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cancer Therapy and Testing Market Share by Type: 2022 VS 2033
Figure 3. Cancer Detection Features
Figure 4. Cancer Treatment Features
Figure 5. Global Cancer Therapy and Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Cancer Therapy and Testing Market Share by Application: 2022 VS 2033
Figure 7. Lung Cancer Case Studies
Figure 8. Rectal Cancer Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. Cancer Therapy and Testing Report Years Considered
Figure 12. Global Cancer Therapy and Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Cancer Therapy and Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Cancer Therapy and Testing Market Share by Region: 2022 VS 2033
Figure 15. Global Cancer Therapy and Testing Market Share by Players in 2022
Figure 16. Global Top Cancer Therapy and Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Therapy and Testing as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cancer Therapy and Testing Revenue in 2022
Figure 18. North America Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Cancer Therapy and Testing Market Share by Country (2018-2033)
Figure 20. United States Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Cancer Therapy and Testing Market Share by Country (2018-2033)
Figure 24. Germany Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Cancer Therapy and Testing Market Share by Region (2018-2033)
Figure 32. China Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Cancer Therapy and Testing Market Share by Country (2018-2033)
Figure 40. Mexico Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Cancer Therapy and Testing Market Share by Country (2018-2033)
Figure 44. Turkey Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Invitae Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 47. Foundation Medicine Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 48. Guardant Health Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 49. Illumina Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 50. Sysmex Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 51. Abingdon Health Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 52. Sophia Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 53. NanoEntek Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 54. BGI Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 55. Diagnosis Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 56. Exact Sciences Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 57. AstraZeneca Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 58. Bayer AG Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 59. Johnson & Johnson Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 60. Pfizer Inc. Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed